Windy City Media Group Frontpage News
Celebrating 30 Years of Gay Lesbian Bisexual and Trans News
home search facebook twitter join
Gay News Sponsor Windy City Times 2018-08-15
DOWNLOAD ISSUE
About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage

Sponsor
Sponsor
Sponsor

  WINDY CITY TIMES

Forum explores Truvada's use in fighting HIV
by Kate Sosin, Windy City Times
2011-06-22

facebook twitter pin it del.icio.us stumble upon digg google +1 reddit email


When Gladstone Institutes released evidence that Truvada, a one-a-day HIV pill, might prevent HIV in addition to treating it, the news sparked both excitement and skepticism.

The AIDS Healthcare Foundation (AHF), the largest HIV/AIDS medical provider in the country, came out against the use of Truvada for prevention, despite the fact that Gladstone's Iniciativa Profilaxis Preexposicion (iPrEx) trial showed the drugs to be more than 90-percent effective in preventing HIV in those who took it daily.

Experts on the study sat down with Feast of Fun podcasters Fausto FernÃ"s and Marc Felion at Center on Halsted June 15 to talk about what the study means and if Truvada could signal the end of the pandemic. Present were Dr. Robert Grant of Gladstone Institute, Keith Green, director of federal affairs at AIDS Foundation of Chicago, and a youth who participated in a similar study Green conducted in Chicago.

"In our wildest dreams, we did not think [Truvada] would be more than 90-percent effective in those who took it," Grant told the audience.

The findings also astounded Green, who halted Project PrEPare, a similar Chicago study, because he didn't want to continue administering placebos when he knew Truvada worked.

While the effectiveness of Truvada in preventing HIV is clear, the practicality of it remains uncertain. For one, Truvada is meant to be taken daily, which could pose a challenge to many not accustomed to the routine or whose lives don't always allow for consistency, such as youth living on the street. Additionally, Truvada is not without side effects including nausea, although that tends to go away over prolonged use, said Grant.

One barrier in getting people to use Truvada is stigma, Grant said.

"These pills, in particular, have been the one thing that folks want to avoid," he said, adding that fear surrounding HIV/AIDS contributes to fear around taking Truvada for prevention. "It strikes people as a misuse [of the drug]."

The drug could cost as much at $10,000 a year, an impossibly high price for people without insurance. In Illinois, the AIDS Drug Assistance Program (ADAP) which provides antiretrovirals to those who cannot afford them, is already cash-strapped. Truvada used for prevention could compete with Truvada treatments, creating a kind of Catch-22 for service providers who want to end the spread of HIV but also serve those who are positive already.

"We really have an ethical dilemma," Green said.

Still, many insurance companies are interested in Truvada for prevention because even with the cost of the drug, prevention is at least half the cost of treatment.

Rico, the youth who participated in Green's Chicago study on Truvada said that taking the drug made him "more considerate" of his body and protecting himself. He said that he had been hesitant to participate in the study but decided to sign up when he learned of the impact it could have on his community.

Grant and Green did acknowledge that iPrEx study had its shortcomings.

"I started to look at Dr. Grant's work, and those people didn't look like our people," Green said, adding that a low number of youth and African Americans had participated. Grant agreed and noted that their efforts would seek the expertise of Chicago service providers whose work included a diversity of clients. Still he added, the drug seemed to work equally well among people of every race.

As for AHF's critiques of using Truvada for prevention, neither Grant nor Green seemed to give them much weight.

"This is a large corporation, actually that has revenues above 300 million dollars a year, so well above my pay grade," said Grant, who went on to say that he was not certain about why AHF was working to discredit the trial results.

Truvada is awaiting FDA approval before it can be marketed for HIV prevention. Grant said that Gilead, the company that makes Truvada, will likely be hesitant to market the drug for prevention and that it will be up to AIDS service providers to make the leap in making Truvada more accessible.

For some, that leap can't come quickly enough.

"We either pay now or we pay forever," Grant said. "We have a chance now to stop this epidemic."


facebook twitter pin it del.icio.us stumble upon digg google +1 reddit email




Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.


  ARTICLES YOU MIGHT LIKE

Panel on LGBTQI+ persecution Aug. 16 at Center on Halsted 2018-08-15
Queer, Ill + Okay hosts 'HIV/AIDS in the Age of PrEP' 2018-08-15
WORLD Report on LGBTQ groups, Costa Rica marriage, Kenyan HIV lab 2018-08-14
Report looks at LGBTs and Alzheimer's, dementias, pushing for better care 2018-08-14
City presses ahead with plans to reduce HIV infections 2018-08-11
Human Rights Watch issues U.S. LGBT healthcare report 2018-08-08
U=U HIV event on Aug. 16 2018-08-08
Anti-racism series Sept. 14-Nov. 17 2018-08-08
Local psychologist hopes to be first gay APA president 2018-08-08
Shriver Center starts Get Care Illinois website 2018-08-08
Lurie study seeks LGBTQ youth 2018-08-08
MOMBIAN Creator of study on LGBTQ familes talks about new findings 2018-08-08
GUEST VIEW: AIDS then and global anti-LGBTQ persecution now--We know what to do 2018-08-06
Panel on LGBTQI+ persecution Aug. 16 2018-08-01
Lurie study seeks LGBTQ youth 2018-08-01
Human Rights Watch issues U.S. LGBT healthcare report, addresses barriers 2018-07-31
NATIONAL Housing lawsuit, AIDS event, trans ICE case, gay men egged 2018-07-31
Same-sex couples more likely than straight to raise adopted, foster kids 2018-07-31
Chicago Foundation for Women announces grants for women's health and freedom 2018-07-31
Howard Brown Health Presents "Let's Talk About PrEP" song and music video 2018-07-30
Federal family planning resource access in peril 2018-07-28
HRC Foundation Releases Asian American, Pacific Islanders Coming Out Resource 2018-07-27
200+ national, state groups oppose allowing adoption agencies to discriminate 2018-07-26
Lambda Legal, Black AIDS Institute start "CUT THE STIGMA" to end HIV discrimination 2018-07-26
Landmark Settlement in Class Action Will Accommodate Deaf Prisoners 2018-07-25
15th annual Disability Pride dedicated to equality 2018-07-25
Protestors challenge youth intersex surgeries 2018-07-25
Mother-son team on Chicago House, other endeavors 2018-07-25
Sykes, Rippon at Sept. 14 Chicago House Speaker Series event 2018-07-25
WORLD Elton John, AIDS confab, Israeli rally 2018-07-24
NATIONAL Conversion therapy, service members, judge withdrawn 2018-07-24
Dads start petition to keep Fed money from anti-LGBTQ adoption agencies 2018-07-24
Eighth Annual Slutwalk Chicago planned for Saturday, July 28 2018-07-24
Public comment ends July 31 on Trump-Pence gag rule 2018-07-23
Global human rights advocates say no 2020 AIDS conference in Trump's USA 2018-07-23
Planned Parenthood of Illinois denounces Trump-Pence domestic gag rule 2018-07-20
Study says mental health of young adults with lesbian parents same as peers 2018-07-18
Lambda Legal, OutServe-SLDN Ask Court to Stop Discharges of HIV+ Service Members 2018-07-18
Day of Unity makes HIV/AIDS a social justice issue 2018-07-12
EJAF Founder Elton John and Duke of Sussex to announce new global AIDS coalition 2018-07-12
 



Copyright © 2018 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 

TRENDINGBREAKINGPHOTOS

Sponsor
Sponsor
Sponsor
Sponsor


 



Sponsor

About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Subscriptions      Distribution      Windy City Queercast     
Queercast Archives      Advertising  Rates      Deadlines      Advanced Search     
Press  Releases      Event Photos      Join WCMG  Email List      Email Blast     
Upcoming Events      Todays Events      Ongoing Events      Submit an Event      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Blogs      Spotlight  Video     
Classifieds      Real Estate      Place a  Classified     

Windy City Media Group produces Windy City Queercast, & publishes Windy City Times,
The Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community,
Nightspots, Out! Resource Guide, and Identity.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.